THERAPEUTIC INNOVATION IN SPINAL CORD INJURY IN BRAZIL: CLINICAL ADVANCES IN POLYLAMININ AND REGULATORY CHALLENGES
DOI:
https://doi.org/10.63330/aurumpub.034-016Palabras clave:
Regenerative medicine, Regulatory challenges, Spinal cord injury, Therapeutic innovation, PolylamininResumen
Spinal cord injury represents a major clinical and social challenge in Brazil, requiring innovative therapeutic strategies capable of promoting neural regeneration and functional recovery. This chapter aims to analyze clinical advances related to the use of polylaminin as a therapeutic biomaterial for spinal cord injury in the Brazilian context, as well as to discuss the main regulatory challenges for its incorporation into the health system. The methodology consisted of a narrative review of national and international scientific literature, in addition to the analysis of regulatory documents concerning clinical research and advanced therapy medicinal products in Brazil. The results indicate that polylaminin shows promising potential in promoting axonal growth, reducing inflammatory response, and improving functional outcomes in experimental models, with prospects for future clinical application. However, regulatory barriers remain, including requirements for safety validation, production standardization, and ethical oversight in clinical trials. It is concluded that although polylaminin represents a significant advance in regenerative medicine, its therapeutic consolidation in Brazil depends on strengthening translational research and regulatory harmonization.
Descargas
Referencias
ANVISA. Agência Nacional de Vigilância Sanitária. Resolução da Diretoria Colegiada – RDC nº 338, de 20 de fevereiro de 2020. Dispõe sobre produtos de terapias avançadas. Diário Oficial da União: seção 1, Brasília, DF, 2020.
ASSIS, A. C.; CARVALHO, J. L.; SILVA, F. A. Estratégias de engenharia tecidual aplicadas à regeneração da medula espinhal. Acta Cirúrgica Brasileira, São Paulo, v. 36, n. 2, p. 1-10, 2021.
BUNGE, M. B. Novel combination strategies to repair the injured mammalian spinal cord. Journal of Spinal Cord Medicine, London, v. 31, n. 3, p. 262-269, 2008.
COURTINE, G.; SOFRONIEW, M. V. Spinal cord repair: advances in biology and technology. Nature Medicine, New York, v. 25, n. 6, p. 898-908, 2019.
FREEDMAN, B. S.; SCHWAB, M. E. Neural regeneration and plasticity after spinal cord injury. Annual Review of Neuroscience, Palo Alto, v. 42, p. 313-334, 2019.
HUBBELL, J. A. Biomaterials in tissue engineering. Bio/Technology, New York, v. 13, n. 6, p. 565576, 1995.
KOFFLER, J.; ZHU, W.; QU, X. et al. Biomimetic 3D-printed scaffolds for spinal cord injury repair. Nature Medicine, New York, v. 25, n. 2, p. 263-269, 2019.
SILVA, João da. O impacto da inteligência artificial na educação moderna. 2. ed. São Paulo: Editora Futuro, 2023. 245 p.
SOFRONIEW, M. V. Dissecting spinal cord regeneration. Nature, London, v. 557, n. 7705, p. 343-350, 2018.
TATOR, C. H.; FEHLINGS, M. G. Review of the secondary injury theory of acute spinal cord trauma. Journal of Neurosurgery, Chicago, v. 75, n. 1, p. 15-26, 1991.
YAMADA, K. M.; SEKIGUCHI, K. Molecular basis of laminin-integrin interactions. Current Opinion in Cell Biology, London, v. 30, p. 1-7, 2014.
Publicado
Número
Sección
Licencia
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
